Search Saint Luke's

Saint Luke’s is participating in the ReBIRTH (Randomized Evaluation of Bromocriptine In Myocardial Recovery Therapy) clinical trial to help develop more effective treatments for peripartum cardiomyopathy.

Recognize a team members commitment to care by nominating them for a DAISY, BEE, or Sunshine Award.

Our doctors, nurses, and staff are committed to working with referring physicians to provide your patients the highest level of care, ensuring the best possible outcomes. Our teams are:

Urinary incontinence affects millions of women, and many believe it’s something they just must live with. It’s not.

Please fill in the fields below to receive more information on Saint Luke’s Mid America Heart Institute.

This form is to be completed in connection with the Saint Luke’s Health System Policy on Conflicts of Interest in Research, RES-052, by all Investigators responsible for Sponsored Research activities, regardless of title or position, who are responsible for the design, conduct, or reporting of Research or proposals for funding of Research. Potential conflicts may be related to Conflicts of Commitment or Financial Interests, as defined by the policy.

New scientific paper proposes SGLT inhibitors as a therapy to slow aging at the cellular level and improve longevity.

The same genes that predispose humans to atherosclerosis, the disease that causes heart attacks and strokes, may have advantages earlier in life, new findings published in the American Heart Association’s scientific journal Circulation suggest.

Saint Luke’s residency and fellowship programs offer students a broad range of experiences while they work alongside physicians and other medical professionals.

Students will provide patient-centered care in a community pharmacy setting under the supervision of the site pharmacy preceptor.